Target intelligence / Profile preview

Phosphatidylinositol 4-kinase alpha pseudogene 1 (PI4KAP1)

Target
PI4KAP1
Molecular classification
Pseudogene
01

Overview

Phosphatidylinositol 4-kinase alpha pseudogene 1 (PI4KAP1) is a human pseudogene located on chromosome 22q11.2 that is highly homologous to the catalytically active phosphatidylinositol 4-kinase alpha (PI4KA) gene, but PI4KAP1 itself does not encode a functional enzyme. PI4KAP1 represents a partial, nonfunctional genetic copy containing segments of the PI4KA gene, particularly coding for part of the catalytic domain. No evidence exists that PI4KAP1 produces an active protein, nor does it participate in biological pathways, disease roles, or serve as a drug target or biomarker. This locus is found in a region of known genetic instability; while PI4KA has established roles in lipid signaling and disease, PI4KAP1 itself is only cataloged as a pseudogene and is not a functional therapeutic target. Key context and supporting details: - PI4KAP1 is officially listed as a pseudogene, not a protein-coding gene, and does not produce a functional phosphatidylinositol 4-kinase enzyme. - It is found at human chromosome 22q11.2, a locus notable for chromosomal instability but is catalytically inactive itself. - Functional and disease data instead apply to its parent gene, PI4KA (phosphatidylinositol 4-kinase alpha), which is an essential lipid kinase implicated in phosphoinositide signaling and several human diseases, but not to PI4KAP1. - The presence of PI4KAP1 may contribute to transcript heterogeneity in cells from this region, but it does not encode an active or druggable protein. - There are no described drugs, mechanisms of action, biomarkers, or safety concerns linked to PI4KAP1, as it is not biologically active. - Most available aliases are minor variants of its full name, corresponding to pseudogene nomenclature, not functional targets. Corrections/clarifications: - The request's target, PI4KAP1, is sometimes confused with the functional enzyme PI4KA; only the latter is a relevant therapeutic target. - As a pseudogene, PI4KAP1 does not fit drug targeting, biomarker, or molecular classification schemes for active receptors, enzymes, or transporters, and is not a therapeutic target.

Other names
phosphatidylinositol 4-kinase, catalytic, alpha pseudogene 1PI4KA pseudogene 1phosphatidylinositol 4-kinase, catalytic, alpha polypeptide pseudogene 1PI4KAP1

Beyond the preview

Go deeper on Phosphatidylinositol 4-kinase alpha pseudogene 1 (PI4KAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 4-kinase alpha pseudogene 1 (PI4KAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call